Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells.
Molecular Cancer
Berlak, Mareike M; Tucker, Elizabeth E; Dorel, Mathurin M; Winkler, Annika A; McGearey, Aleixandria A; Rodriguez-Fos, Elias E; da Costa, Barbara Martins BM; Barker, Karen K; Fyle, Elicia E; Calton, Elizabeth E; Eising, Selma S; Ober, Kim K; Hughes, Deborah D; Koutroumanidou, Eleni E; Carter, Paul P; Stankunaite, Reda R; Proszek, Paula P; Jain, Neha N; Rosswog, Carolina C; Dorado-Garcia, Heathcliff H; Molenaar, Jan Jasper JJ; Hubank, Mike M; Barone, Giuseppe G; Anderson, John J; Lang, Peter P; Deubzer, Hedwig Elisabeth HE; Künkele, Annette A; Fischer, Matthias M; Eggert, Angelika A; Kloft, Charlotte C; Henssen, Anton George AG; Boettcher, Michael M; Hertwig, Falk F; Blüthgen, Nils N; Chesler, Louis L; Schulte, Johannes Hubertus JH